The Medicines Company CEO Clive Meanwell, An Interview With "The Pink Sheet" DAILY (Part 3)
This article was originally published in The Pink Sheet Daily
Executive Summary
Known as a specialty pharma focused on acquiring abandoned late-stage programs from other companies, TMC now is trying to differentiate itself in the industry with what Meanwell calls the company's "human strategy."